Then, they summarized the different investigated BC biomarkers, i.e., circulating tumor cells (CTCs), circulating serum carcinoma proteins (CA153, CA27-29, CA-125, CEA), circulating cell-free tumor DNAs, circulating miRNAs, different Extracellular Vesicles (EVs), and many others such as proteins, carbohydrates, lipids and metabolites. This evidence concerns the gene CEACAM5 and carcinoma.